Home » Topics » Regulatory » Patents

Patents
RSS

IMPACT Therapeutics identifies wee1-like protein kinase inhibitors

Jan. 30, 2019

Coagulation factor XI inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

Jan. 30, 2019

Shanghai Institute of Materia Medica discloses PARP-1/2 inhibitors

Jan. 30, 2019

New beta-lactamase inhibitors discovered at Sumitomo Dainippon Pharma

Jan. 30, 2019

New PD-1/PD-L1 interaction inhibitors described by Rijksuniversiteit Groningen

Jan. 30, 2019

U.S. Department of Health & Human Services patents fatty acid derivatives

Jan. 30, 2019

GlaxoSmithKline presents new CREB-2 inhibitors

Jan. 30, 2019

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine describe RORC agonists/inverse agonists

Jan. 29, 2019

Selection Bioscience patents indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 29, 2019

Peking University discovers STAT3 inhibitors

Jan. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...